{{Rsnum
|rsid=33428
|Gene=ZNF536
|Chromosome=19
|position=30446936
|Orientation=plus
|GMAF=0.3701
|Gene_s=ZNF536
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 7.1 | 36.3 | 56.6
| HCB | 47.8 | 45.6 | 6.6
| JPT | 37.2 | 44.2 | 18.6
| YRI | 2.7 | 25.2 | 72.1
| ASW | 1.8 | 31.6 | 66.7
| CHB | 47.8 | 45.6 | 6.6
| CHD | 39.4 | 46.8 | 13.8
| GIH | 41.6 | 41.6 | 16.8
| LWK | 7.3 | 33.6 | 59.1
| MEX | 24.1 | 51.7 | 24.1
| MKK | 5.1 | 34.6 | 60.3
| TSI | 5.9 | 45.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=3E-6
  |OR=1.38
  |ORtxt=[1.160-1.629]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}